
Theratechnologies THTX
Theratechnologies ROA | THTX
ROA Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.57 | -30.81 | -50.65 | -26.61 | -22.63 | -423.02 | -4.23 | -24.18 | 0.77 | 3.14 | -32.28 | -16.92 | -38.11 | -34.59 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.14 | -423.02 | -51.12 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Denali Therapeutics
DNLI
|
-44.77 | $ 18.43 | 1.29 % | $ 3.18 B | ||
|
Pfizer
PFE
|
3.73 | $ 27.4 | -0.62 % | $ 156 B | ||
|
Amarin Corporation plc
AMRN
|
-5.78 | $ 10.56 | -6.26 % | $ 4.38 B | ||
|
ImmuCell Corporation
ICCC
|
-2.45 | $ 11.08 | -0.81 % | $ 100 M | ||
|
Editas Medicine
EDIT
|
-85.81 | $ 1.63 | -4.68 % | $ 145 M | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
7.73 | $ 93.83 | 0.32 % | $ 6.96 B | ||
|
Agios Pharmaceuticals
AGIO
|
-31.84 | $ 27.54 | -4.24 % | $ 1.6 B | ||
|
Royalty Pharma plc
RPRX
|
3.93 | $ 68.45 | 1.08 % | $ 29.4 B | ||
|
Equillium
EQ
|
-70.24 | $ 1.06 | -5.36 % | $ 60.7 M | ||
|
Black Diamond Therapeutics
BDTX
|
15640.17 | $ 1.32 | -5.04 % | $ 75.1 M | ||
|
Abeona Therapeutics
ABEO
|
-32.42 | $ 2.42 | -1.17 % | $ 128 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
25.0 | $ 17.1 | -2.79 % | $ 2.88 B | ||
|
Atossa Therapeutics
ATOS
|
-73.03 | $ 1.6 | -8.86 % | $ 13.8 M | ||
|
Cleveland BioLabs, Inc.
CBLI
|
-103.47 | - | -7.31 % | $ 49 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-0.04 | $ 112.31 | -3.84 % | $ 7.3 B | ||
|
Five Prime Therapeutics, Inc.
FPRX
|
-25.43 | - | - | $ 1.77 B | ||
|
ADC Therapeutics SA
ADCT
|
-44.13 | $ 1.29 | -2.28 % | $ 164 M | ||
|
Harmony Biosciences Holdings
HRMY
|
12.48 | $ 32.58 | -1.21 % | $ 1.87 B | ||
|
Ardelyx
ARDX
|
-12.36 | $ 2.99 | -2.25 % | $ 721 M | ||
|
Akebia Therapeutics
AKBA
|
-1.41 | $ 0.39 | -8.41 % | $ 100 M | ||
|
Alector
ALEC
|
-48.77 | $ 2.34 | 1.52 % | $ 241 M | ||
|
ALX Oncology Holdings
ALXO
|
-172.23 | $ 1.06 | 3.43 % | $ 56.9 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.96 | $ 21.12 | -1.26 % | $ 6.62 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-35.41 | $ 4.03 | -1.11 % | $ 772 M | ||
|
Agenus
AGEN
|
-1.36 | $ 5.97 | -2.85 % | $ 178 M | ||
|
PolyPid Ltd.
PYPD
|
-153.18 | $ 6.1 | -6.87 % | $ 99.7 M | ||
|
AbCellera Biologics
ABCL
|
-10.79 | $ 9.63 | -8.02 % | $ 2.88 B | ||
|
Artelo Biosciences
ARTL
|
-459.8 | $ 1.35 | -6.9 % | $ 255 K | ||
|
Immatics N.V.
IMTX
|
-34.93 | $ 5.76 | -3.19 % | $ 705 M | ||
|
Aptevo Therapeutics
APVO
|
-95.49 | $ 0.4 | -2.61 % | $ 126 K | ||
|
Aligos Therapeutics
ALGS
|
-27.33 | $ 1.22 | -2.4 % | $ 12.1 M | ||
|
Aclaris Therapeutics
ACRS
|
-40.46 | $ 3.44 | -1.86 % | $ 422 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-11.6 | $ 27.46 | -2.1 % | $ 4.17 B | ||
|
Cellectar Biosciences
CLRB
|
-145.48 | $ 0.83 | -8.27 % | $ 2.16 M | ||
|
Biofrontera AG
BFRA
|
-23.09 | - | -8.24 % | $ 105 M | ||
|
SIGA Technologies
SIGA
|
10.61 | $ 2.4 | -9.06 % | $ 172 M | ||
|
Catabasis Pharmaceuticals, Inc.
CATB
|
-78.6 | - | -6.97 % | $ 657 M | ||
|
Capricor Therapeutics
CAPR
|
-29.51 | $ 7.56 | 0.4 % | $ 351 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 28.3 | 0.68 % | $ 1.32 B | ||
|
China Biologic Products Holdings, Inc.
CBPO
|
6.74 | - | 1.68 % | $ 4.65 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
-20.48 | $ 55.64 | 2.88 % | $ 155 M | ||
|
Syndax Pharmaceuticals
SNDX
|
-53.88 | $ 8.71 | -4.16 % | $ 755 M | ||
|
Aquestive Therapeutics
AQST
|
-52.23 | $ 3.47 | -6.48 % | $ 371 M | ||
|
Pliant Therapeutics
PLRX
|
66.29 | $ 0.59 | -4.42 % | $ 36.2 M | ||
|
Jaguar Health
JAGX
|
-0.14 | $ 0.24 | -27.06 % | $ 560 K | ||
|
Arvinas
ARVN
|
-11.28 | $ 6.41 | -4.9 % | $ 454 M | ||
|
Cerus Corporation
CERS
|
-7.04 | $ 1.86 | -2.37 % | $ 355 M | ||
|
Beam Therapeutics
BEAM
|
-5.4 | $ 20.87 | -0.36 % | $ 2.06 B | ||
|
Inhibrx
INBX
|
-78.39 | $ 68.81 | -7.43 % | $ 3.24 B | ||
|
Scholar Rock Holding Corporation
SRRK
|
-93.5 | $ 48.09 | -4.54 % | $ 5.52 B |